High-sensitivity C-reactive protein and cardiovascular disease: A resolute belief or an elusive link?
Although high-sensitivity C-reactive protein (hsCRP) is involved in the immunologic process that triggers vascular remodeling and plaque deposition and is associated with increased cardiovascular disease (CVD) risk, definitive randomized evidence for its role as a causative factor in atherothrombosis is lacking. This article reviews four distinct points from the literature to better understand the current state and application of hsCRP in clinical practice, and we highlight recommendations from societies and important considerations when using hsCRP to guide treatment decisions in the primary prevention setting.
- Journal: Journal of the American College of Cardiology
- Year: 2013
- Topic: Cardiovascular Risk Assessment, Inflammation
- Read more articles by: Roger S. Blumenthal, MD, Michael Blaha, MD, MPH, Khurram Nasir, MD, MPH, Seth Martin, MD, MHS
